Outdoor travel

AdvantageClub.ai raises $4 Million from Axilor Ventures to expand in the US and Asia and add New Product Lines

MANILA,Philippines,Dec. 2,2024-- AdvantageClub.ai,a leader in employee engagement solutions,has raised $4 million in its latest funding round,bringing its total funding to $11 million. The round was l

12-04 AdvantageClub.ai

Hong Kong Airlines Resumes Vancouver Service Offering Twice-weekly direct flights from 18 January 2025

HONG KONG,Dec. 2,2024-- Hong Kong Airlines celebrated its 18th anniversary on 28 November and announced the resumption of direct flights to Vancouver,Canada commencing 18 January 2025. The twice-weekl

12-04 Hong Kong Airlines

Sustainable Energy Brand EBL to Unveil New Brand Identity and Innovative Power Solutions at CES 2025

SHENZHEN,China,Dec. 2,2024-- EBL,a pioneering sustainable energy brand committed to environmental protection,efficiency,and stability,is proud to announce that it will unveil its new brand image at CE

12-04 EBL

Hesai to Attend CES 2025, Launch Versatile New Mini 3D Lidar for Industrial and Robotic Applications

PALO ALTO,Calif.,Dec. 2,2024--Hesai (Nasdaq: HSAI),the global leader in lidar technology for robotics and industrial applications,autonomous driving,and ADAS,announced today that it will be exhibiting

12-04 Hesai Technology

Aon names Anne Corona as CEO of Enterprise Clients and Global Chief Commercial Officer

DUBLIN,Dec. 3,2024--Aon plc (NYSE: AON),a leading global professional services firm,today announces the appointment of Anne Corona as CEO of Enterprise Clients and global chief commercial officer,effe

12-04 Aon plc

Moon Creative Lab Venture Variloom™ Wins ISPO 2024 Award in Collaboration with Rip Curl

Variloom3DP Filament and Print System Recognized as Part of Rip Curl\'s Mirage3DP Boardshort Innovating in Sustainable and Functional Design and Materials

12-04 Moon Creative Lab

Fangzhou Inc. Announces Inclusion of Its Shares in Hang Seng Hong Kong-Listed Biotech Index

HONG KONG,Dec. 3,2024-- Fangzhou Inc.("Fangzhou" or the "Company") (06086.HK),a leader in Internet healthcare solutions,announced today that the Company\'s Ordinary Shares,which t

12-04 Fangzhou Inc.

VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Post-Operative Inflammation Following Cataract Surgery

VVN461,a non-steroidal dual JAK1/TYK2 immunomodulator,achieves primary endpoint,demonstrating statistical and clinical efficacy compared to vehicle in treatingpost-operative inflammation following cat

12-04 VIVAVISION BIOTECH LTD

TraceLink Announces Grant Recipients Driving Impact Across the Globe

BOSTON,Dec. 3,2024-- TraceLink,the largest end-to-end digital network platform for intelligent orchestration of the supply chain,has announced the recipients of its 2024 corporate grant program. The

12-04 Tracelink, Inc.

Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to use FDA-approved mapping and dual energy ablation catheter

AUSTIN,Texas,Dec. 4,2024-- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David\'s Medical Center recently became the first in the nation to usean all-in-one high-density

12-04 Texas Cardiac Arrhythmia Institute at St. David’s Medical Center